Physician

Gregory G Nowak, MD

According to 2025 Medicare claims, Gregory Nowak, MD (NPI: 1376516625) practices cardiology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is ROCKFORD HEALTH PHYSICIANS (NPI: 1043242886; TIN: 363907436) and primary practice location at 61114-2300. Nowak is affiliated with the Mercy Health Corporation (ACO ID: A2097) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Nowak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,932 traditional Medicare patients, billed 8,363 HCPCS/CPT codes, and received $217,581 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 17,132 prescription claims across 1,810 beneficiaries totaling $2,307,448 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 3 records totaling $66. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $319,185 to $2,307,448. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,027 and ending at $30,634.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,049	4,959	$227,837
2016	2,202	5,424	$240,292
2017	1,963	4,987	$228,524
2018	1,640	4,539	$192,921
2019	2,106	5,031	$191,171
2020	2,367	5,272	$180,631
2021	2,438	5,813	$203,307
2022	2,176	5,155	$177,505
2023	2,682	7,148	$217,340
2024	2,932	8,363	$217,581

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	578	6,932	$319,185
2016	660	7,918	$446,382
2017	740	8,224	$525,332
2018	862	8,586	$598,435
2019	1,018	9,949	$683,324
2020	1,276	12,269	$1,065,717
2021	1,416	13,409	$1,447,368
2022	1,503	14,235	$1,634,919
2023	1,715	14,986	$2,103,627
2024	1,810	17,132	$2,307,448

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$2,942
2016	N/R	52	$44,561
2017	N/R	15	$750
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	35	$44,813
2021	N/R	38	$33,478
2022	N/R	N/R	N/R
2023	N/R	16	$31,507
2024	N/R	12	$28,959

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	643	741	$66
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	308	309	$56
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	647	659	$50
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	188	188	$15
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,362	3,780	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	880	48,709	$936,349
Repatha Sureclick	Evolocumab	225	13,900	$271,459
Xarelto	Rivaroxaban	218	13,725	$254,766
Entresto	Sacubitril/Valsartan	145	9,152	$201,764
Jardiance	Empagliflozin	129	8,130	$161,204

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	12	$28,959

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$66	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory G. Nowak, MD?

Tedicare shows public-source Medicare data for Gregory G. Nowak, MD (NPI 1376516625), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory G. Nowak, MD have ACO affiliation data?

Gregory G. Nowak, MD is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Gregory G. Nowak, MD?

Gregory G. Nowak, MD is linked to ROCKFORD HEALTH PHYSICIANS (billing NPI 1043242886) in the available physician profile data.

Does Gregory G. Nowak, MD have Open Payments data?

Gregory G. Nowak, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.